Cowpox Virus Inhibits the Transporter Associated with Antigen Processing to Evade T Cell Recognition

被引:66
作者
Alzhanova, Dina [1 ]
Edwards, David M. [1 ]
Hammarlund, Erika [1 ]
Scholz, Isabel G. [1 ]
Horst, Danielle [2 ,3 ]
Wagner, Mary J. [4 ]
Upton, Chris [4 ]
Wiertz, Emmanuel J. [2 ,3 ]
Slifka, Mark K. [1 ]
Frueh, Klaus [1 ]
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
[2] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands
[3] Leiden Univ, Dept Med Microbiol, Med Ctr, NL-2300 RC Leiden, Netherlands
[4] Univ British Columbia, Victoria, BC V8W 3P6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
CLASS-I MOLECULES; MONKEYPOX VIRUS; PROTEIN ICP47; HEAVY-CHAINS; MUTANT MICE; PEPTIDE; TAP; TAPASIN; CYTOMEGALOVIRUS; IMMUNITY;
D O I
10.1016/j.chom.2009.09.013
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Cowpox virus encodes an extensive array of putative immunomodulatory proteins, likely contributing to its wide host range, which includes zoonotic infections in humans. Unlike Vaccinia virus, cowpox virus prevents stimulation of CD8(+) T cells, a block that correlated with retention of MHC class I in the endoplasmic reticulum by the cowpox virus protein CPXV203. However, deletion of CPX203 did not restore MHC class I transport or T cell stimulation. Here, we demonstrate the contribution of an additional viral protein, CPXV12, which interferes with MHC class I/peptide complex formation by inhibiting peptide translocation by the transporter associated with antigen processing (TAP). Importantly, human and mouse MHC class I transport and T cell stimulation was restored upon deletion of both CPXV12 and CPXV203, suggesting that these unrelated proteins independently mediate T cell evasion in multiple hosts. CPXV12 is a truncated version of a putative NK cell ligand, indicating that poxviral gene fragments can encode new, unexpected functions.
引用
收藏
页码:433 / 445
页数:13
相关论文
共 34 条
[1]
Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47 [J].
Ahn, K ;
Meyer, TH ;
Uebel, S ;
Sempe, P ;
Djaballah, H ;
Yang, Y ;
Peterson, PA ;
Fruh, K ;
Tampe, R .
EMBO JOURNAL, 1996, 15 (13) :3247-3255
[2]
BACIK I, 1994, J IMMUNOL, V152, P381
[3]
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11 and -B7 [J].
Bakker, Arnold H. ;
Hoppes, Rieuwert ;
Linnemann, Carsten ;
Toebes, Mireille ;
Rodenko, Boris ;
Berkers, Celia R. ;
Hadrup, Sine Reker ;
van Esch, Wirn J. E. ;
Heemskerk, Mirjam H. M. ;
Ovaa, Huib ;
Schumacher, Ton N. M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) :3825-3830
[4]
VACCINATION WITH THE IMMEDIATE-EARLY PROTEIN ICP47 OF HERPES-SIMPLEX VIRUS-TYPE-1 (HSV-1) INDUCES VIRUS-SPECIFIC LYMPHOPROLIFERATION, BUT FAILS TO PROTECT AGAINST LETHAL CHALLENGE [J].
BANKS, TA ;
JENKINS, FJ ;
KANANGAT, S ;
NAIR, S ;
DASGUPTA, S ;
FOSTER, CM ;
ROUSE, BT .
VIROLOGY, 1994, 200 (01) :236-245
[5]
Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation [J].
Barel, MT ;
Pizzato, N ;
Le Bouteiller, P ;
Wiertz, EJHJ ;
Lenfant, F .
INTERNATIONAL IMMUNOLOGY, 2006, 18 (01) :173-182
[6]
BAXBY D, 1997, ARCH VIROL S, V13, P1
[7]
Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface [J].
Byun, Minji ;
Wang, Xiaoli ;
Pak, Melissa ;
Hansen, Ted H. ;
Yokoyama, Wayne M. .
CELL HOST & MICROBE, 2007, 2 (05) :306-315
[8]
Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules [J].
Dasgupta, Anindya ;
Hammarlund, Erika ;
Slifka, Mark K. ;
Frueh, Klaus .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1654-1661
[9]
Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus [J].
Edghill-Smith, Y ;
Golding, H ;
Manischewitz, J ;
King, LR ;
Scott, D ;
Bray, M ;
Nalca, A ;
Hooper, JW ;
Whitehouse, CA ;
Schmitz, JE ;
Reimann, KA ;
Franchini, G .
NATURE MEDICINE, 2005, 11 (07) :740-747
[10]
FEUERBACH D, 1994, J IMMUNOL, V153, P1626